QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.

Slides:



Advertisements
Similar presentations
Introduction to Pharmacology
Advertisements

LAKSHMAN KARALLIEDDE OCTOBER 2011
DRUG-RECEPTOR INTERACTIONS
QUANTITATIVE ASPECTS OF DRUG ACTIONS DR. SHABANA ALI.
QUANTITATIVE ASPECTS OF DRUG ACTION
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Chapter 5 Pharmacodynamics 1.
Pharmacology-1 PHL 313 Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Dose-Response Relationships Lesson 6. Dose & Drug Effects n Pharmacodynamics l what the drug does to the body n Effects of drug depends on dose n In general...
Pharmacology Introduction
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Drug-Receptor Interactions Pharmacodynamics
Principles of Pharmacology: Pharmacodynamics

Principles of Pharmacology: Pharmacodynamics
Fundamentals of Drug Action
PHC 222 Part(I) Dr. Huda Al Salem Lecture (7). Factors that affect the efficacy 2- Concentration-Response Curves: Agonist Antagonist Partial agonist Desensetization.
Types of antagonists. Antagonists, Overview  Definition “An antagonist is a substance that does not provoke a biological response itself, but blocks.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
HuBio 543 September 6, 2007 Frank F. Vincenzi
Mechanisms of drug action. pharmacodynamics  What the drug does to the body  This illustrates on the process of which drug alters the body environment,
How drugs Act :General principles Lecture 2
Year One Pharmacodynamics
PHARMACOLOGY INTRODUCTION
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
At the end of this lecture, the students will be able to: 1.Define receptors 2.Define agonists 3.List types of agonists 4. Define antagonists 5. List.
MEDC 603 Fall Measuring Drug Action  Dose – Response Curves Response  fraction bound (fb) = Fraction bound [D] [D] = K D R + D R:D.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
Biological Evaluation Lecture - 4 Principles and Importance of BA’s Joseph O. Oweta B. Pharm (MUST)
Pharmacodynamics. Pharmacodynamics  The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects.
DRUG RECEPTORS AND PHARMACODYNAMICS
QUANTITATIVE ASPECTS OF DRUG ACTION
Section 1, Lecture 8 Receptor Classification according to: -which drugs they interact with (  -adrenergic –binds norepinphine with high affinity.
INTRODUCTION Lecture 3. Pharmacodynamics Receptor: macromolecule that interacts with a drug and initiates the chain of biochemical events leading to the.
Dept. Pharmacology & Therapeutic Universitas Sumatera Utara
Pharmacodynamics What the drug does to the body?
Pharmacodynamics Collected and Prepared By S.Bohlooli, PhD.
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
OMICS International OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.
5 Pharmacodynamics.
Pharmacodynamics 3.
Toxicology Drug Poisioning.
DRUG ANTAGONISM DR. SHABANA ALI.
MBBS-BDS LECTURE NOTES
Introduction Pharmacology is the study of the biochemical and physiological aspects of the drug effects including absorption, distribution, metabolism,
Brief Review of Dr. Swanson’s and Dr. Prakriya’s material
Toxicology Drug Poisioning.
5 Pharmacodynamics.
Drug-Receptor Interactions
INTRODUCTION to Pharmacology
Pharmacodynamics 2.
Principles of pharmacodynamics
Pharmacology UG-Course
Drug-Receptor Interactions
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Efficacy, Potency and Safety of Drugs
Drug ½ life time it takes plasma concentration or amount of drug in body to be reduced by 50% Provides a good indication of the time necessary to reach.
ANTAGONISTS Antagonists are substances which block the action of agonists There are a number of types COMPETITIVE NON-COMPETITIVE PARTIAL AGONISTS PHYSIOLOGICAL.
Drug-Receptor Interaction
Introduction to Pharmacology
Drug-Receptor Interactions and Pharmacodynamics (cont.)
Non-competitive antagonism
Drug- Receptor Interaction
Drug-Receptor Interaction
Presentation transcript:

QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different types of antagonism  Determine quantitative aspects of drug receptor binding  Distinguish the therapeutic utility of each of these curves

DOSE RESPONSE CURVE QUANTAL DOSE RESPONSE CURVE GRADED DOSE RESPONSE CURVE

A continuous response  BP, HR, FBG, Cholesterol,… GRADED DOSE RESPONSE CURVE

% of Maximal Effect [C] GRADED DOSE RESPONSE CURVE Max effect = E max Effect when all the receptors are occupied by D C that gives the half-maximal effect E= E max xC C+ EC 50 As C ↑  response increment ↓ % of Maximal Effect [C] EC 50 Graded dose-response curves are used to determine: 1.The max efficacy ( E max ) → highest limit of dose-response relationship on response axis. 2.The potency = The concentration of drug required to produce a specified response The smaller the EC 50, the greater the potency of the agonist, i.e the lower C needed to elicit the maximum biological response. 3. Compare the relative potency and efficacy of drugs that produce the same effect. EC 50

GRADED DOSE RESPONSE CURVE A > efficacy than B B Partial Agonist EFFICACY POTENCY A > potent B

X > potent than Y & Z X & Z > efficacy than YX & Z are equal efficacy Y> potent than Z GRADED DOSE RESPONSE CURVE Y > potent but < efficacious than Z

DOSE RESPONSE CURVE QUANTAL DOSE RESPONSE CURVE GRADED DOSE RESPONSE CURVE

QANTAL DOSE RESPONSE CURVE All-non responses * specified therap. response * adverse response * lethal outcome % subjects responding Dose-frequency relationship

[Dose] ED 50 % subjects responding QANTAL DOSE RESPONSE CURVE: used to determine TD 50 LD 50 50% of individuals exhibit the specified therapeutic response Median toxic doseMedian lethal doseMedian Effective Dose Predict the safety profile Therapeutic Index The relation between dose to induce a desired effect versus that producing the unwanted effect. TD 50 ED 50 When low → the drug has a narrow margin of safety digoxin When high → the drug has a safe profile diazepam Therapeutic Effect Toxic Effect Lethal Effect

Physiological Chemical PharmacokineticNon- Competitive It is the diminution or the complete abolishment of the effect of one drug in the presence of another. Receptor Blockade Competitive Two drugs react chemically resulting in loss of activity of active drug Two drugs possess opposing actions in the body, so tend to cancel each other’s effect The antagonist effectively reduces the concentration of the active drug at the site of action Phenobarbitone induces an accelerated hepatic metabolism warfarine Omeprozole & histamine ANTAGONISM Dimercaprol reduces heavy metal toxicity [ lead, ….]

Receptor Blockade Competitive Non- Competitive Antagonist prevents binding of agonist to the receptor at the same binding site ( = competes with it at same occupancy site ) Antagonist block at some point the chain of events that ignite the response of agonist Agonist and Antagonist can be bound simultaneously Agonist and Antagonist compete ( only one is bound) ANTAGONISM Irreversible Reversible

Antagonist readily dissociate from binding site of agonist to the receptor Antagonist form stable, permanent / near permanent chemical bond with receptor. Inactivation lasts for duration of receptor turnover or its de- novo synthesis → explains its longevity of action Surmountable Antagonism can be overcomed by increasing concentration of agonist = Surmountable Phenoxybenzamine & Noradrenaline Atropine vs Ach Irreversible COMPETATIVE ANTAGONISM

Parellel shift to the right, without any change in slope or maximum No parellel shift but both a decrease in slope and a reduced maximum are obtained. Competitive Antagonism Irreversible Reversible

Agonist Agonist + irreversible competitive antagonist Agonist + non-competitive antagonist % of Maximal Effect [C] NON-SURMOUNTABLE Antagonism cannot be overcomed by increasing concentration of agonist = NON-SURMOUNTABLE Agonist + reversible competitive antagonist Competitive vs Noncompetative Antagonism Depression of maximal response +/- rightward shifts ( if some R are spare ) SURMOUNTABLE Antagonism can be overcomed by increasing concentration of agonist = SURMOUNTABLE Verapamil vs noradrenaline

QUANTITATIVE ASPECTS OF DRUG ACTION By the end of this lecture you ARE able to :  Recognize different dose response curves  Classify different types of antagonism  Determine quantitative aspects of drug receptor binding DDistinguish the therapeutic utility of each of these curves